Li Ding
Impact in
- Immunology top 2%
- Immunodeficiency and Autoimmune Disorders
- Infectious Diseases top 2%
- Tuberculosis Research and Epidemiology
- Antifungal resistance and susceptibility
Papers in ⓘ
-
- Extracellular vesicles in disease 17
- Epidemiology 37
- Mycobacterium research and diagnosis 13
- Co-authors
- Steven M. Holland (33 shared papers)Yu Chen (24 shared papers)Wei Feng (9 shared papers)Caihong Dong (8 shared papers)Meiqi Chang (13 shared papers)Wen Shi (1 shared paper)Yinghong Wang (1 shared paper)Jianlin Shi (3 shared papers)
- Journals
- Advanced Functional Materials (6 papers)Chinese Chemical Letters (5 papers)Annals of Translational Medicine (5 papers)Advanced Materials (4 papers)Journal of Clinical Immunology (3 papers)
- Partner nations
- ChinaUnited StatesBrazil
In The Last Decade
Li Ding
157 papers receiving 4.7k citations
Hit Papers
Peers
Comparison fields: 5 of 168
- Immunology 963
- Infectious Diseases 727
- Biomaterials 388
- Epidemiology 990
- Biomedical Engineering 1.1k
Countries citing papers authored by Li Ding
This map shows the geographic impact of Li Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li Ding more than expected).
Fields of papers citing papers by Li Ding
This network shows the impact of papers produced by Li Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li Ding. The network helps show where Li Ding may publish in the future.
Co-authors
The 25 scholars most cited alongside Li Ding, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 166 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 221 | |
| 2 | 2018 | 194 | |
| 3 | 2013 | 177 | |
| 4 | 2005 | 152 | |
| 5 | 2017 | 151 | |
| 6 | 2012 | 124 | |
| 7 | 2020 | 119 | |
| 8 | 2021 | 115 | |
| 9 | 2017 | 112 | |
| 10 | 2010 | 108 | |
| 11 | 2006 | 99 | |
| 12 | 2016 | 84 | |
| 13 | 2006 | 84 | |
| 14 | 2021 | 84 | |
| 15 | 2021 | 82 | |
| 16 | Therapeutic effectiveness of bacteriophages in the rescue of mice with extended spectrum beta-lactamase-producing Escherichia coli bacteremia. | 2006 | 70 |
| 17 | 2022 | 70 | |
| 18 | 2006 | 69 | |
| 19 | 2020 | 66 | |
| 20 | 2018 | 64 |
About Li Ding
Li Ding is a scholar working on Molecular Biology, Epidemiology, Biomedical Engineering, Immunology and Pulmonary and Respiratory Medicine, having authored 166 papers that have together received 4.8k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (25 papers), Extracellular vesicles in disease (17 papers), Mycobacterium research and diagnosis (13 papers), Immunodeficiency and Autoimmune Disorders (10 papers), Traditional Chinese Medicine Analysis (7 papers), Ferroptosis and cancer prognosis (7 papers), Advanced Nanomaterials in Catalysis (7 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (7 papers). The work is most often cited by research in Immunology (963 citations), Infectious Diseases (727 citations), Biomaterials (388 citations), Epidemiology (990 citations) and Biomedical Engineering (1.1k citations). Li Ding has collaborated with scholars based in China, United States and Brazil. Frequent co-authors include Steven M. Holland, Yu Chen, Wei Feng, Caihong Dong, Meiqi Chang, Wen Shi, Yinghong Wang, Jianlin Shi, Hui Huang and Luodan Yu. Their work appears in journals such as Advanced Functional Materials, Chinese Chemical Letters, Annals of Translational Medicine, Advanced Materials and Journal of Clinical Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.